CAS No. |
65807-02-5 |
中文名称 |
(S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-吲哚-3-基)甲基)-1-氨基-12-(叔丁氧甲基)-6-((S)-2-(2-氨甲酰肼-1-基羰基)吡咯烷-1-基羰基)-15-(4-羟基苄基)-18-(羟甲基)-25-(1H-咪唑-4-基)-1-亚氨基-9-异丁基-8,11,14,17,20,23-六氧代-2,7,10,13,16,19,22-七氮杂二十五烷-24-基)-5-氧代吡咯烷-2-羧酰胺 |
英文名称 |
(S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-4-yl)-1-imino-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacosan-24-yl)-5-oxopyrrolidine-2-carboxamide |
别名 |
GOSERELIN ACETATE SALT;(D-SER(TBU)6,AZAGLY10)-GONADOTROPIN-RELEASING HORMONE ACETATE SALT;(D-SER(TBU)6,AZAGLY10)-LHRH ACETATE SALT;(D-SER(TBU)6,AZAGLY10)-LUTEINIZING HORMONE-RELEASING FACTOR ACETATE SALT;(D-SER(TBU)6,AZAGLY10)-LUTEINIZING HORMONE-RELEASING HORMONE ACETATE SALT;PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE SALT;2-(aminocarbonyl)hydrazide;decapeptidei |
标准英文名 |
(S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-4-yl)-1-imino-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacosan-24-yl)-5-oxopyrrolidine-2-carboxamide |
分子式 |
C59H84N18O14 |
分子量 |
1269.43
|
精确分子量 |
1268.64
|
SMILES |
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O |
标准SMILES |
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O |
用途 |
Goserelin acetate is a synthetic analog of gonadotropin-releasing hormone (GnRH), with 50–100 times greater potency than the natural hormone. It is used in endocrine therapy for advanced prostate cancer; for hormone-responsive breast cancer in premenopausal and perimenopausal women; and for the management of endometriosis, where it alleviates symptoms. In prostate cancer, it suppresses serum testosterone to castration levels; in women, it reduces serum estradiol to postmenopausal levels. |
InChIKey |
BLCLNMBMMGCOAS-URPVMXJPSA-N |